productio

  • Chloramphenicol & Dexamethasone test habena

    Chloramphenicol & Dexamethasone test habena

    Hoc ornamentum fundatur in competitive indirecte immunochromatography technology, in quo chloramphenicol & dexamethasone in Sample certat in colloid aurum intitulatum Antigen et Chloramphenicol & Dexamethasone couplucto antigen captum in test linea. Test consequitur observari nudo oculo.

  • Fluoroquinolones & Tetracyclines & Gentamycin Triple Test habena

    Fluoroquinolones & Tetracyclines & Gentamycin Triple Test habena

    Hoc ornamentum fundatur in competitive indirecte immunochromatography technology, in quo fluoroquinolones & tetracyclines & gentamycin in specimen certat ad colloid aurum intitulatum et in Fluoroquinolones & Tetracyclines & Gentamycin Iungled in Test & Test. Test consequitur observari nudo oculo.

  • Fluoroquinolones & Tylosin & Lincomycin Triple Test habena

    Fluoroquinolones & Tylosin & Lincomycin Triple Test habena

    Hoc ornamentum fundatur in competitive indirecte immunochromatography technology, in quo fluoroquinolones & Tylosin & Lincomycin in Sample certat in colloid aurum intitulatum antibody et fluoroquinolones & Tylosin & Lincomycin couplucat in Test Line. Test consequitur observari nudo oculo.

  • & Tylosin & Tilmicosin Lincomycin & Erythromycin quadruplae test habena

    & Tylosin & Tilmicosin Lincomycin & Erythromycin quadruplae test habena

    Hoc ornamentum fundatur in competitive indirecte immunochromatography technology, in quo Vincomycin & Tylosin & Tilmicosin & Erythromycin in Sample C. & Tylosin & Tilmicosin & Erythromycin & Tylosin & Tilmicosin & Erythromycin couplucat & Testa. Test consequitur observari nudo oculo.

  • Beta-Lactams & Cefalexin Test habena

    Beta-Lactams & Cefalexin Test habena

    Hoc ornamentum fundatur in competitive indirectis immunochromatography technology, in quo beta-lactams & Cefalexin in specimen certat in colloid aurum intitulatum antigen captum-lactams & Cefalexin couplucet in Test Linter. Test consequitur observari nudo oculo.

  • Fluoroquinolones & Tylosin & Lincomycin & Erythromycin Test habena

    Fluoroquinolones & Tylosin & Lincomycin & Erythromycin Test habena

    Hoc ornamentum fundatur in competitive indirecte immunochromatography technology, in quo fluoroquinolones & Tylosin & Lincomycin & Erythromycin in Sample Certat in Colloid & Tylosin & Lincomycin & Erythromycin couplucat & Tylosin & Lincomycin & Erythromycin couplucat & Testa. Test consequitur observari nudo oculo.

  • Beta-Lactans & Streptomycin & Chloramphenicol & Tetracyclines quadruplae test habena

    Beta-Lactans & Streptomycin & Chloramphenicol & Tetracyclines quadruplae test habena

    This kit is based on competitive indirect immunochromatography technology, in which Beta-lactans & Streptomycin & Chloramphenicol & Tetracyclines in sample competes for the colloid gold labeled antibody with Beta-lactans & Streptomycin & Chloramphenicol & Tetracyclines coupling antigen captured on test line. Test consequitur observari nudo oculo.

  • Beta-Lactams & Tetracyclines test habena

    Beta-Lactams & Tetracyclines test habena

    Hoc ornamentum fundatur in competitive indirecte immunochromatography technology, in quo beta-lactams & tetracyclines in specimen certat ad colloid aurum intitulatum, cum beta-Lactams & tetracyclines couplucat in Test acie. Test consequitur observari nudo oculo.

  • Neomycin Residue Elisa Kit

    Neomycin Residue Elisa Kit

    Hoc ornamentum est a generatione medicamento residuum deprehendatur productum developed ab Elisa technology. Comparari cum instrumento analysis technology, quod habet proprietates ex ieiunium, simplex, accurate et princeps sensibilitatem. Operatio est solum XLV min, quod potest minimize operationem errores et opus intensionem.

    Quod productum potest deprehendere neomycin residuum in vaccine, pullum et lac specimen.

  • Sulfanilanlamide XVII-in-I Residue Elisa Kit

    Sulfanilanlamide XVII-in-I Residue Elisa Kit

    Hoc ornamentum est a generatione medicamento residuum deprehendatur productum developed ab Elisa technology. Comparari cum instrumento analysis technology, quod habet proprietates ex ieiunium, simplex, accurate et princeps sensibilitatem. Operatio est tantum XLV minutes, quod potest minimize operationem errores et opus intensionem.

  • Neomycin celeri test habena

    Neomycin celeri test habena

    Hoc ornamentum fundatur in competitive indirecte immunochromatography technology, in quo neomycin in specimen certat in colloid aurum intitulatum Antibdy cum Neomycin couplucet antigen captum in test linea. Test consequitur observari nudo oculo.

  • Spectinomycin Test habena

    Spectinomycin Test habena

    Hoc ornamentum fundatur in competitive indirecte immunochromatography technology, in quo spectinomycin in sample certat in colloid aurum intitulatum, cum Spectinomycin cooptibilem antigen captum in test linea. Test consequitur observari nudo oculo.